The emigration of leukocytes into injured tissues is a critical step in inflammation. A variety of cell adhesion molecules are involved in this event. The initial step of the inflammation, termed rolling, is mediated by the interaction between selectins and their specific carbohydrate ligands. There are three selectins, L-, E-, and P-selectin, with a C-type lectin domain, an epidermal growth factor (EGF)-like domain, repeats of complement regulatory-like units, a transmembrane domain, and a cytoplasmic region. Although all selectins bind a common carbohydrate structure, sialyl Lewisx (SLex), the resultant binding is very weak (low affinity). For high affinity interactions, specific aglycons that express SLex determinant are required. However, although numerous biochemical studies demonstrated amino acid residues that account for high affinity interaction between selectins and their specific ligands, especially P-selectin and PSGL-1 (Pselectin glycoprotein ligand-1), the molecular mechanisms for the high affinity binding have not been elusive. A tremendous paper introduced here answered the molecular basis for the highaffinity binding of PSGL-1 to P-selectin, but not E-selectin The authors generated two Ig-fusion proteins containing lectin and EGF domains of P-selectin and E-selectin (P-LE and E-LE). They succeeded in crystalyzing these proteins with or without ligands such as a SLex sugar chain or N-terminal peptide of PSGL-1 modified with sulfation of tyrosine residues and native O-glycosylation of Thr residue that are required for high affinity binding to P-selectin [Sako, D., et al. (1993 ) Cell 75, 1179 , Ramachandran, V., et al. (1999 Proc. Natl. Acad. Sci, USA 96, 13771]. 3-D structures of P-selectin (P-LE), E-and Pselectins complexed with SLex (E-LE/SLex, P-LE/SLex), and P-selectin with the PSGL-1 peptide, termed SGP-3 (P-LE/SGP-3), are resolved at 2.4, 1.5, 3.4 and 1.9 A, respectively. By comparison of P-LE/SLex with E-LE/SLex, Lys99 and Arg97 in L-LE make more favorable contacts with hydroxyl and carboxyl groups of NeuNAc residue of SLex than Ser99 and Ser97 in P-LE. Furthermore, Asn83 in E-LE, but not in P-LE, contributes considerably to the interaction with hydroxyl groups of fucose residue by ligation of calcium ion. These observations agree well with better binding of E-selectin to SLex sugar chain than that of P-selectin. A highlight of the study is the crystal structure of P-LE complexed with SGP-3, a part of the high affinity ligand for P-selectin, PSGL-1. As compared with the structure of P-LE with SLex, drastic changes in conformation of binding domain in P-LE with SGP-3 allow sulfo-tyrosine residues at 48 and 51 in N-terminal of PSGL-1 to directly contact with His114 and Arg85 of P-LE, respectively. Since Leu114 and Gln85 of E-LE correspond to His 114 and Arg85, the interaction of E-LE with sulfo-tyrosine residues of SGP-3, N-terminal of PSGL-1, never happens. That is a critical mechanism for the high affinity interaction of P-selectin, but not E-selectin, with PSGL-1.
This work is a milestone in the elucidation of biological significance of posttranslational modifications, such as glycosylation and sulfation. Now we understand the molecular basis of the high affinity interaction of P-selectin with PSGL-1. According to the structural information about P-selectin and PSGL-1, we could develop anti-inflammatory reagents computationally. Very recently, another striking paper has come out. Both SLex sugar chain and N-terminal residue of PSGL-1 expressed on human granulocytes is a receptor for rickettsia that causes a newly emerging disease, granulocytic ehrlichiosis [Herron, MJ, et al. (2000) Science 288, 1653], suggesting that adhesin-like molecules of the parasite recognizing N-terminal of PSGL-1 potentially form similar structures to the lectin domain of P-selectin. The structural information introduced here will also be very powerful tools to develop anti-parasite reagents.
